# CorMedix Inc. (CRMD) stock: price and valuation

URL: https://funkfolio.com/stock/CRMD

> CorMedix Inc. (CRMD) trades at $4.67, is worth $371.44M, is priced at 7.3× earnings and scores 69/100. Valuation, financials and signals.

---

## CorMedix Inc. (CRMD)

CorMedix Inc. (CRMD) is a healthcare company (biotechnology) based in the United States. The share price is $4.67, down 3.11% on the day, which values the company at $371.44M. Price as of 18 Nov 2026, 11:47 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $4.67 −3.11% today
- **Market value:** $371.44M
- **P/E ratio:** 7.3× last 12 months
- **Forward P/E:** 13.3×
- **Funk Score:** 69/100
- **200-week average:** $7.22 35% below
- **Sector:** Healthcare

Figures as of 18 Nov 2026, 11:47 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### CorMedix Inc. in more detail

CRMD trades at 7.3× its last twelve months' earnings, 13.3× next year's expected earnings, 0.9× sales. It sits 35% below its 200-week average of $7.22.

Over the last five fiscal years CorMedix Inc. has compounded revenue 319.7% a year. Its Funk Score is 69 out of 100 (financial strength 6.7, profitability 8.2, growth 7.8, value 5.0, each out of 10).

In its favour: High return on invested capital. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

### CorMedix Inc. (CRMD): questions and answers

**What is CRMD's P/E ratio?**

CorMedix Inc. trades at 7.3× its last twelve months' earnings and 13.3× next year's expected earnings.

**What is CRMD's PEG ratio?**

CorMedix Inc.'s PEG ratio is 3.44 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is CorMedix Inc.'s market cap?**

CorMedix Inc. is valued at $371.44M at a share price of $4.67.

**Is CRMD above its 200-week moving average?**

No. CRMD is 35.3% below its 200-week average of $7.22. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is CorMedix Inc. growing?**

Over the last five fiscal years CorMedix Inc.'s revenue grew 319.7% a year; over ten years revenue grew 107.6% a year.

**Does CRMD pay a dividend?**

CorMedix Inc. does not currently pay a regular dividend.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “CorMedix Inc. (CRMD) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/CRMD

Underlying data: Yahoo Finance; company filings with the SEC.
